Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pawel Muranski

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|July 19, 2023
Case Report: Kinetics and durability of humoral and cellular response of SARS-CoV-2 messenger RNA vaccine in a lung and kidney transplant recipientJames Long, Mithil Soni, Pawel Muranski, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 13, 2016
Adenosine Selectively Depletes Alloreactive T Cells to Prevent GVHD While Conserving Immunity to Viruses and LeukemiaGreg D Whitehill, Shoba Amarnath, Pawel Muranski, et al.
Nature Clinical Practice. Oncology|December 2, 2006
Increased intensity lymphodepletion and adoptive immunotherapy--how far can we go?Pawel Muranski, Andrea Boni, Claudia Wrzesinski, et al.
Cell Reports|October 7, 2020
Bone Morphogenic Proteins Are Immunoregulatory Cytokines Controlling FOXP3<sup>+</sup> T<sub>reg</sub> CellsLauren M Browning, Caroline Miller, Michal Kuczma, et al.
Cytotherapy|November 2, 2013
Genetically engineered fixed K562 cells: potent "off-the-shelf" antigen-presenting cells for generating virus-specific T cellsKazushi Tanimoto, Pawel Muranski, Samantha Miner, et al.
Bone Marrow Transplantation|December 27, 2025
CAR T-cells in multiple myeloma: the race to the start lineAbdul-Hamid Bazarbachi, Divaya Bhutani, Michael Sang Hughes, et al.
Haematologica|November 22, 2015
PPARγ antagonist attenuates mouse immune-mediated bone marrow failure by inhibition of T cell functionKazuya Sato, Xingmin Feng, Jichun Chen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 3, 2009
Increased intensity lymphodepletion enhances tumor treatment efficacy of adoptively transferred tumor-specific T cellsClaudia Wrzesinski, Chrystal M Paulos, Andrew Kaiser, et al.
The Journal of Experimental Medicine|February 17, 2010
Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanomaYing Xie, Akgül Akpinarli, Charles Maris, et al.
Cytotherapy|June 29, 2021
Development of T-cell immunity in a liver and hematopoietic stem cell transplant recipient following coronavirus disease 2019 infectionMithil Soni, Edoardo Migliori, Amer Assal, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|July 19, 2023
Case Report: Kinetics and durability of humoral and cellular response of SARS-CoV-2 messenger RNA vaccine in a lung and kidney transplant recipientJames Long, Mithil Soni, Pawel Muranski, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 13, 2016
Adenosine Selectively Depletes Alloreactive T Cells to Prevent GVHD While Conserving Immunity to Viruses and LeukemiaGreg D Whitehill, Shoba Amarnath, Pawel Muranski, et al.
Nature Clinical Practice. Oncology|December 2, 2006
Increased intensity lymphodepletion and adoptive immunotherapy--how far can we go?Pawel Muranski, Andrea Boni, Claudia Wrzesinski, et al.
Cell Reports|October 7, 2020
Bone Morphogenic Proteins Are Immunoregulatory Cytokines Controlling FOXP3<sup>+</sup> T<sub>reg</sub> CellsLauren M Browning, Caroline Miller, Michal Kuczma, et al.
Cytotherapy|November 2, 2013
Genetically engineered fixed K562 cells: potent "off-the-shelf" antigen-presenting cells for generating virus-specific T cellsKazushi Tanimoto, Pawel Muranski, Samantha Miner, et al.
Bone Marrow Transplantation|December 27, 2025
CAR T-cells in multiple myeloma: the race to the start lineAbdul-Hamid Bazarbachi, Divaya Bhutani, Michael Sang Hughes, et al.
Haematologica|November 22, 2015
PPARγ antagonist attenuates mouse immune-mediated bone marrow failure by inhibition of T cell functionKazuya Sato, Xingmin Feng, Jichun Chen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 3, 2009
Increased intensity lymphodepletion enhances tumor treatment efficacy of adoptively transferred tumor-specific T cellsClaudia Wrzesinski, Chrystal M Paulos, Andrew Kaiser, et al.
The Journal of Experimental Medicine|February 17, 2010
Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanomaYing Xie, Akgül Akpinarli, Charles Maris, et al.
Cytotherapy|June 29, 2021
Development of T-cell immunity in a liver and hematopoietic stem cell transplant recipient following coronavirus disease 2019 infectionMithil Soni, Edoardo Migliori, Amer Assal, et al.
Pageof 7